Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
المؤلفون الرئيسيون: | Sandham, D, Chen, W, Hardman, C, Luo, J, Xue, L, Ogg, G, Erpenbeck, V |
---|---|
التنسيق: | Conference item |
اللغة: | English |
منشور في: |
Wiley
2019
|
مواد مشابهة
-
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
حسب: Chen, W, وآخرون
منشور في: (2018) -
Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
حسب: Xue, L, وآخرون
منشور في: (2018) -
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
حسب: Hardman, C, وآخرون
منشور في: (2019) -
Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
حسب: Xue, L, وآخرون
منشور في: (2019) -
IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
حسب: Hardman, CS, وآخرون
منشور في: (2021)